{"transactions":[{"id":4634556,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Voting Common Stock","published_at":"2026-10-03T00:46:55.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"25% of the restricted stock units (\"RSUs\") shall vest on September 30, 2028, with the remaining 75% of the RSUs vesting on the earlier of (i) reporting of completion of the pivotal trial of TSC-101, or (ii) September 30, 2030, subject to continued service with the Issuer through the applicable vesting dates and the terms of the Issuer's Amended and Restated 2021 Equity Incentive Plan and the applicable award agreement."}],"balance_after":1049767,"source":{"system":"sec-edgar","filing":"0001193125-26-412521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000119312526412521/ownership.xml","form_type":"4"}},{"id":933446,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-22T22:48:44.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":1165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 20, 2026, with the balance vesting thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":1165000,"derivative":{"exercise_price":1.12,"expiration_date":"2036-01-20","underlying":"Voting Common Stock","underlying_shares":1165000},"source":{"system":"sec-edgar","filing":"0001193125-26-019723","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000119312526019723/ownership.xml","form_type":"4"}},{"id":1274087,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T22:52:57.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer."}],"balance_after":800000,"derivative":{"exercise_price":3.065,"expiration_date":"2035-01-03","underlying":"Voting Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000950170-25-018125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017025018125/ownership.xml","form_type":"4"}},{"id":1274086,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T22:52:57.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 12, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer."}],"balance_after":160000,"derivative":{"exercise_price":6,"expiration_date":"2034-01-12","underlying":"Voting Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000950170-25-018125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017025018125/ownership.xml","form_type":"4"}},{"id":1854478,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T22:08:34.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":1121300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"536,300 shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of May 24, 2023, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer. The remaining 585,000 shares subject to this option shall vest and become exercisable with respect to 25% of the shares on February 2, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer, in each case subject to the Reporting Person's continued service at such time. This option was granted on May 24, 2023 subject to the approval of the Issuers' stockholders of an amendment to the TScan Therapeutics, Inc. 2021 Equity Incentive Plan, which was obtained on June 13, 2023."}],"balance_after":1121300,"derivative":{"exercise_price":2.49,"expiration_date":"2033-06-12","underlying":"Voting Common Stock","underlying_shares":1121300},"source":{"system":"sec-edgar","filing":"0000899243-23-015635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924323015635/doc4.xml","form_type":"4"}},{"id":2030676,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-06T22:16:55.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":40000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-02-01","underlying":"Voting Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-23-004062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924323004062/doc4.xml","form_type":"4"}},{"id":2201371,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-27T20:30:25.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following July 25, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":3.27,"expiration_date":"2032-07-24","underlying":"Voting Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-026844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322026844/doc4.xml","form_type":"4"}},{"id":2430696,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:26:58.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following January 18, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":140000,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-17","underlying":"Voting Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000899243-22-002651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322002651/doc4.xml","form_type":"4"}},{"id":2562118,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Voting Common Stock","published_at":"2021-09-22T22:48:47.000Z","date":"2021-09-21","kind":"purchase","acquired":true,"shares":57,"price":6.188,"value":352.716,"ownership":{"direct":true},"balance_after":49767,"source":{"system":"sec-edgar","filing":"0000899243-21-037147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924321037147/doc4.xml","form_type":"4"}},{"id":2562117,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69001,"kind":"person","name":"MacBeath Gavin","position":1,"cik":"0001738082","reported_name":"MacBeath Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Voting Common Stock","published_at":"2021-09-22T22:48:47.000Z","date":"2021-09-20","kind":"purchase","acquired":true,"shares":4943,"price":6.2197,"value":30743.9771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $6.09 to $6.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":49710,"source":{"system":"sec-edgar","filing":"0000899243-21-037147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924321037147/doc4.xml","form_type":"4"}}]}